This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Original paper

Advancing continuous subcutaneous insulin infusion in vivo: New insights into tissue challenges

Volume: 109, Issue: 7, Pages: 1065 - 1079
Published: Sep 18, 2020
Abstract
Continuous Subcutaneous Insulin Infusion (CSII) is superior to conventional insulin therapy as it improves glycemic control thus reducing the probability of diabetic complications. Notwithstanding CSII's benefits, insulin dependent diabetic patients rarely achieve optimal glucose control. Moreover, CSII is only FDA approved for 3 days and often fails prematurely for reasons that have not been fully elucidated. We hypothesize that phenolic...
Paper Details
Title
Advancing continuous subcutaneous insulin infusion in vivo: New insights into tissue challenges
Published Date
Sep 18, 2020
Volume
109
Issue
7
Pages
1065 - 1079
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.